P value | CABG group (n = 195) | PCI group (n = 898) |
|
0 .001 | 40 ± 2 | 39 ± 3 | Age (years) |
0.02 | 141 (72.3%) | 718 (80%) | Sex (male) |
0.001 | 26.9± 4.3 | 28.2 ± 4.7 | BMI (kg/m2) |
0.9 | 106 (54.4%) | 492 (54.8%) | Current Smoking (%) |
0.001 | 100 (51.3%) | 319 (35.5%) | Family history of CAD (%) |
0.001 | 80 (41%) | 221 (24.6.1%) | Diabetes mellitus (%) |
0.005 | 92 (47.2%) | 335 (37.3%) | Dyslipidemia (%) |
0.001 | 96 (49.2%) | 311 (34.6%) | Hypertension (%) |
0.11 | 8 (4.4%) | 19 (2.1%) | CVA history (%) |
0.7 | 3 (1.7%) | 11 (1.2%) | COPD (%) |
1 | 1 (0.6%) | 9 (1%) | PVD (%) |
0.013 | 11 (7.9%) | 28 (3.1%) | Renal failure (%) |
0.03 | 131 (67.2%) | 673 (74.9%) | BMI ≥ 25 (kg/m2) |
0.2 | 92 (52.3%) | 423 (47.1%) | Previous MI (%) |
0.001 | 3 (1.9%) | 113 (12.7%) | Previous surgery (%) |
0.001 | 8 (1.9%) | 134 (14.9%) | Thrombolytic therapy (%) |
0.02 | 44 ± 11 | 47 ± 11 | LVEF (%) |